Marshall Posner, MD
- PROFESSOR | Medicine, Hematology and Medical Oncology
- PROFESSOR | Otolaryngology
Specialties:Cancer (Oncology), Hematology-Oncology
Research Topics:AIDS/HIV, Anti-Tumor Therapy, Cellular Immunity, Immunology, Tumorigenesis, Viruses and Virology
Dr. Posner is Professor of Medicine, Director of Head and Neck Medical Oncology, Associate Director of the Center for Personalized Cancer Therapeutics, and Co-Leader of the Cancer Clinical Investigation Program for The Tisch Cancer Institute. Dr. Posner has been engaged in clinical and translational research in cancers of the head and neck, HIV, and immunity for more than 40 years. He develops therapies to optimize treatment and advance early diagnosis and screening; he developed the TPF chemotherapy regimen for induction chemotherapy in head and neck cancer and curative rituximab therapy for Pemphigus Vulgaris. Dr. Posner’s current research is in the area of virally caused head and neck cancers. He is also investigating models that translate genetic findings into therapeutic treatment. Dr. Posner has served on numerous NCI study sections and review committees. He has authored over 250 peer reviewed clinical, laboratory and translational scientific publications covering cancer therapeutics, monoclonal antibodies and immunology, autoimmune disease, and infectious diseases.
In the News:
Dr. Posner discusses HPV-related oral cancer in the New York Times.
Dr. Posner discusses the warning signs of oral cancer and what to watch out for on the Katie Couric show.
The ASCO Post features Dr. Posner discussing "Challenges, Progress, and Future Directions in Head and Neck Cancer" (March 1, 2012)
Dr. Marshall Posner discusses the link between HPV and oropharyngeal cancers in The Daily News feature The Daily Check Up.
- Adenoid Cystic Carcinoma (ACC)
- Head and Neck Cancers
- Merkel Cell Tumors
- Nasal Cancer
- Nasal Cavity Cancer
- Nasopharyngeal Cancer (NPC)
- Oral Cavity Cancer
MD, Tufts University School of Medicine
Residency, Internal Medicine, Boston City Hospital
Fellowship, Medical Oncology, Dana Farber Cancer Institute
Ninth Warton Visiting Professor, Prince Margaret Hospital
Tisch Award for Clinical Research, Dana-Farber Cancer Institute
Alpha Omega Alpha, Medical Honor Society
HPV and Human Oropharyngeal Cancer
Translational studies to understand the biology and immunology of HPV related oropharyngeal cancer in order to inform therapeutic and preventative therapies in this disease.
Clinical Studies in Head and Neck Cancer
Development of curative therapeutics for patients with HPV positive and negative head and neck cancer, through clinical trials, drug development and translational studies using conventional chemotherapy, novel biotherapeutics vaccines and gene therapies.